United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News India-based Piramal Pharma secures $490m investment from Carlyle Group The Carlyle Group has signed a deal worth around $490 million with Piramal Enterprises, to acquire a stake… bypharmanewsdailyJune 30, 2020
